Elective Abdominal Aortic Aneurism - Open Versus Endovascular Repair (ACE)

March 31, 2009 updated by: Assistance Publique - Hôpitaux de Paris

ACE Trial :Not Worn-Out Aneurism of the Abdominal Aorta Under Renal " Surgery Versus Endoprosthesis "

Abdominal aortic aneurysm (AAA) is a life threatening disease. There is a consensus to propose surgical repair in patients with a reasonable operative risk when the AAA exceeds 5 cm in diameter.

The aim of the study is to compare the mortality and the occurrence of severe general, vascular and local complications in two groups of patients treated by either by open surgery or by EVAR (EndoVascular Aneurysm Repair). The main outcome criteria and the secondary endpoint are respectively the survival without severe complications and minor morbidity.

Study Overview

Detailed Description

ACE Trial :Not Worn-Out Aneurism of the Abdominal Aorta Under Renal " Surgery Versus Endoprosthesis Abdominal aortic aneurysm (AAA) is a life threatening disease. There is a consensus to propose surgical repair in patients with a reasonable operative risk when the AAA exceeds 5 cm in diameter.

The aim of the study is to compare the mortality and the occurrence of severe general, vascular and local complications in two groups of patients treated by either by open surgery or by EVAR (EndoVascular Aneurysm Repair). The main outcome criteria and the secondary endpoint are respectively the survival without severe complications and minor morbidity.

Study Type

Interventional

Enrollment (Actual)

306

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Creteil, France, 94 010
        • Hôpital Henri Mondor

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients aged 50 years old or more (more than 80 possible depending on physiological age)
  • Level 0, 1, or 2 of operative risk
  • Abdominal aortic aneurysm with a diameter > or equal to 50 mm or > or equal to 40 mm if rapid growing (10 mm or more in a year), or painful, or saccular aneurysms, or aneurisms of common iliac arteries with a diameter equal or superior to 30 mm; or women with a diameter equal to 45 mm;
  • Aortic neck superior or equal to 1.5 cm
  • No stenosis superior or equal to 75% of the superior mesenteric artery
  • Proximal neck angulation inferior to 80°
  • Diameter of the iliac arteries compatible with introducer sheath
  • Inform consent signed

Exclusion Criteria:

  • Aneurysm involving the renal arteries or with the length of the neck less than 1.5 cm
  • Thrombus or major calcification in the neck
  • Diameter of the iliac arteries not compatible with introducer sheath
  • Level 3 of operative risk
  • History of major iodine allergy (Quincke oedema, anaphylactic shock)
  • Other comorbidity with life expectancy less than 6 months
  • Follow up impossible during the trial
  • Participation in another trial
  • Inform consent not signed

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: 1
surgery - open repair
Conventional repair consist in open repair. Different types of surgery can be done : minimal incision aortic surgery (MIAS), transperitoneal approach (TPA), retroperitoneal repair, or conventional median laparotomy.
Experimental: 2
endovascular procedure
An endovascular stent graft is a tube composed of fabric supported by a metal mesh called a stent. It can be used for a variety of conditions involving the blood vessels, but most commonly to reinforce a weak spot in an artery called an aneurysm. Over time, blood pressure and other factors can cause this weak area to bulge like a balloon and eventually enlarge and rupture. The stent graft seals tightly with your artery above and below the aneurysm. The graft is stronger than the weakened artery and allows blood to pass through it without pushing on the bulge. Physicians typically use endovascular stent grafting to treat abdominal aortic aneurysms (AAAs).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Death and major adverse events
Time Frame: 4 years
4 years

Secondary Outcome Measures

Outcome Measure
Time Frame
Minor adverse events (systemic vascular or non vascular complications)
Time Frame: 4 years
4 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yann JOUSSET, MD, CHU Angers - Hôtel Dieu
  • Principal Investigator: Jean M Pernes, MD, Hôpital privé d'Antony
  • Principal Investigator: Pierre Y Meaulle, MD, Clinique mutualiste des Eaux Claires, Grenoble
  • Principal Investigator: Jean P Favre, MD, CHU Hôpital Nord, Saint-Etienne
  • Principal Investigator: Jacques Watelet, MD, Hôpital Charles Nicolle, Rouen
  • Principal Investigator: Patrick Lermusiaux, MD, CHRU -Hôpital Trousseau, Tours
  • Principal Investigator: Jean F Heautot, MD, CHU de Pontchaillou, Rennes
  • Principal Investigator: Mohamad KOUSSA, MD, Hôpital Cardiologique , Lille
  • Principal Investigator: Patrice BERGERON, MD, Hôpital St Joseph, Marseille
  • Principal Investigator: Philippe CHAILLOU, MD, Hôpital Nord Laennec, Nantes
  • Principal Investigator: Eric CHEYSSON, MD, Centre Hospitalier René Dubos, Pontoise
  • Principal Investigator: Arnaud DEMON, MD, Ch de Valenciennes
  • Principal Investigator: Jean C PILLET, MD, Nouvelles Cliniques Nantaises, Nantes
  • Principal Investigator: Eric STEINMETZ, MD, CHU de Dijon - Hopital Du Bocage
  • Principal Investigator: Michel LEVADE, MD, Clinique Pasteur Toulouse
  • Principal Investigator: Jean CARDON, MD, Clinique des Franciscaines, Nimes
  • Principal Investigator: Pierre-Edouard MAGNAN, MD, CHU Timone, Marseille
  • Principal Investigator: Michel Batt, MD, Hôpital St-Roch, Nice
  • Principal Investigator: Pierre GOUNY, MD, Hopital de la cavale blanche, Brest
  • Principal Investigator: Antoine Lucas, MD, CHU Pontchaillou
  • Study Chair: Jean P Becquemin, MD, Hopital Henri Mondor, Creteil
  • Study Chair: Marc Sapoval, MD, HEGP, Paris

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2003

Primary Completion (Actual)

February 1, 2008

Study Completion (Actual)

February 1, 2009

Study Registration Dates

First Submitted

September 16, 2005

First Submitted That Met QC Criteria

September 19, 2005

First Posted (Estimate)

September 23, 2005

Study Record Updates

Last Update Posted (Estimate)

April 1, 2009

Last Update Submitted That Met QC Criteria

March 31, 2009

Last Verified

February 1, 2009

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Elective Abdominal Aortic Aneurysm

Clinical Trials on Open repair

Subscribe